Is Intuitive Surgical Stock a Buy Now?
With its shares up by 45% over the last 12 months, Intuitive Surgical (NASDAQ: ISRG) is once again proving its growth stock chops to its shareholders. The robotic surgery company is rapidly recovering from the headwinds it experienced due to the pandemic, and it's aiming to grow its business again at full speed.
What's more, its runway for growth is incredibly long. But with such an optimistic setup and no obvious obstacles at the moment, it's no wonder the stock's valuation is a bit heady. So is Intuitive Surgical stock too hot to touch, or is it worth buying right now? Let's analyze and find out.
Over the last few years, Intuitive's story hasn't changed much, and its razor-and-blade business model is as stellar as ever. It developed the the da Vinci robotic surgical suite, which is a surgeon-controlled set of robotic arms designed for minimally invasive general, bariatric, and urology surgeries.
Source Fool.com
Vinci S.A. Aktie
Aktuell gibt es mit 0 Sell-Einschätzungen und 1 Buy-Einschätzungen noch kein wirkliches Sentiment für die Vinci S.A. Aktie.
Das Community-Kursziel von 120 € für Vinci S.A. deutet auf ein leicht positives Wachstumspotenzial gegenüber 111.1 € hin.
